Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

Author： Martin Laura   Kem William   Freedman Robert  

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.174, Iss.1, 2004-06, pp. : 54-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

7 Nicotinic Receptor Agonists as Potential Therapeutic Drugs for Schizophrenia

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 3, 2005-09 ,pp. : 171-184

Bentham Science Publishers

Access to resources Recommend Favorite

7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 121-129

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Acetylcholine Receptor Agonists: A Potential New Class of Analgesics

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 3, 2004-01 ,pp. : 369-384

Bentham Science Publishers

Access to resources Recommend Favorite

Treating the Cognitive Deficits of Schizophrenia with Alpha4Beta2 Neuronal Nicotinic Receptor Agonists

By  

Current Pharmaceutical Design, Vol. 16, Iss. 3, 2010-01 ,pp. : 309-322

Bentham Science Publishers

Access to resources Recommend Favorite

Neurotensin Agonists: Potential in the Treatment of Schizophrenia

By Boules Mona  

CNS Drugs, Vol. 21, Iss. 1, 2007-01 ,pp. : 13-23

Adis International

Access to resources Recommend Favorite